Adds to existing law to provide for disclosure and labeling of certain blood intended for blood transfusions and to provide that a person receiving a blood transfusion shall have the right to request blood based on vaccination status of the donor.
Summary
House Bill 131 would amend Idaho law to create a new section in Title 39 governing blood donations for transfusions. It requires entities that collect human blood to ask donors whether they have ever received a COVID-19 vaccine or any messenger RNA (mRNA) vaccine, and it requires blood from such donors to be clearly and conspicuously marked. The bill also gives a transfusion recipient, in a nonemergency situation as determined by the medical provider, the right to request blood based on the donor’s vaccination status if that blood is available.
The bill declares an emergency and would take effect on July 1, 2025. In practical terms, it would impose new disclosure and labeling obligations on blood collection and transfusion systems in Idaho and create a patient-request right tied to donor vaccination status. The measure focuses specifically on COVID-19 and mRNA vaccination history and does not otherwise alter general transfusion standards outside this new disclosure framework.
Impact
The bill would add a new statutory requirement in Idaho Code section 39-3704, affecting blood collection organizations, blood banks, hospitals, and other providers involved in transfusions. It would require donor screening for COVID-19 and mRNA vaccination history, mandate labeling of blood from those donors, and authorize patient requests for blood based on that status in nonemergency settings. The law would therefore create new compliance, documentation, and inventory-segregation obligations for medical providers and blood suppliers, while also giving transfusion recipients a limited right to request specific blood products when available.
Sentiment
The available voting history suggests the bill had meaningful support in the House, passing third reading 53-17. That margin indicates the measure was favored by a majority but not broadly unanimous. No committee transcript is available here, so the record does not show detailed debate, but the vote pattern suggests the bill was politically salient and somewhat divisive rather than routine or consensus-driven.
Contention
The main point of contention is the bill’s requirement to disclose and label blood based on a donor’s COVID-19 or mRNA vaccination status. Supporters likely view the measure as expanding patient choice and transparency in transfusion decisions, especially for nonemergency care. Opponents are likely to object that the bill singles out a medically irrelevant characteristic, could complicate blood supply operations, and may conflict with standard blood banking and transfusion practices. The emergency clause and the focus on vaccination status, rather than broader donor health screening, are also likely to be controversial.